Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948490 · ClinicalTrials.gov registry record · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
A NA study of Low Grade Glioma, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 1
- Study location
NCT03948490 is a NA study of Low Grade Glioma that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 97 participants, below the 110-participant average among 23 other Low Grade Glioma trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03948490, a NA study of Low Grade Glioma, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with glial brain tumors have increasingly improved outcomes, with median survival of 5-15 years. However, the treatments, including surgery, radiation, and chemotherapy, often lead to impaired attention, working memory, and other cognitive functions. These cognitive deficits frequently have significant impact on patient quality of life. Although currently, there is no established standard of care to treat cognitive deficits in brain tumor patients, standard cognitive rehabilitative treatments have been developed for those with traumatic brain injury and stroke. However, the feasibility and efficacy of these cognitive treatments in individuals with brain tumors remains unclear.
Conditions Studied
Interventions
- DEVICE ReMind iPad app
- DEVICE Healthy SMS texting
- BEHAVIORAL In-person cognitive rehabilitation
- BEHAVIORAL Telehealth cognitive rehabilitation
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2019-06-07 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03948490
The ClinicalTrials.gov registry entry for NCT03948490 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 110-participant average among 23 other Low Grade Glioma trials with a reported enrollment target (12% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Grade Glioma appearing as the primary indexed condition, and to 4 interventions - of which ReMind iPad app is the first listed.
NCT03948490 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03948490 about?
NCT03948490 is a clinical study titled "Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas". Patients with glial brain tumors have increasingly improved outcomes, with median survival of 5-15 years. However, the treatments, including surgery, radiation, and chemotherapy, often lead to impaired attention, working memory, and other cognitive functions. These cognitive deficits frequently have...
What is the current status of trial NCT03948490?
This trial is currently recruiting. It is a NA study. The enrollment target is 97 participants. The study started on 2019-06-07. Estimated completion is 2026-03-31.
What conditions does trial NCT03948490 study?
This clinical trial studies the following conditions: Low Grade Glioma.
What interventions are being tested in trial NCT03948490?
The interventions under investigation include: ReMind iPad app (DEVICE), Healthy SMS texting (DEVICE), In-person cognitive rehabilitation (BEHAVIORAL), Telehealth cognitive rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03948490?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03948490 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Grade Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
Mind-Body Intervention in Glioma Couples
ACTIVE NOT RECRUITING · NA
-
Proton Radiation Therapy for Gliomas
ACTIVE NOT RECRUITING · NA
-
A Vaccine Trial for Low Grade Gliomas
RECRUITING · Phase 2
-
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
RECRUITING · Phase 1
-
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.